NEW YORK (GenomeWeb News) — MDS today reported that fourth-quarter revenue for its Sciex division declined 5.5 percent to $69 million from $73 million year over year.
 
The company blamed the decline on currency effects but said organic revenues were up 1 percent.
 
MDS said Sciex’s organic increases came from growth in the small-molecule business and high-end triple quad and trap products, and from growth in India and China.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.